Search | IOVS | ARVO Journals

Showing 1 – 20 of 24

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Morphological changes of vascular structures in OCT angiography in MacTel type 2 and quantification of vascular density and flow areas in disease progression.

Frederic Gunnemann; Henrik Faatz; Albrecht Lommatzsch; Nathanael Suckert; Marie-Louise Farecki; Kai Rothaus; Daniel Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3140. doi:

ARVO Annual Meeting Abstract July 2018

OCT angiography of type 1 and 2 CNV in exudative AMD under anti-VEGF therapy: Evaluation of a new quantitative method

Henrik Faatz; Marie-Louise Farecki; Kai Rothaus; Frederic Gunnemann; Matthias Gutfleisch; Albrecht Lommatzsch; Daniel Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3218. doi:

ARVO Annual Meeting Abstract June 2017

Changes in OCT-Angiography of type 2 CNV in neovascular AMD during anti-VEGF treatment.

Henrik Faatz; Marie-Louise Farecki; Britta Heimes; Rothaus Kai; Albrecht Lommatzsch; Daniel Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):403. doi:

ARVO Annual Meeting Abstract September 2016

Proteomic changes in ARPE-19 cells stimulated with complement serum and UV-irradiated photoreceptor outer segments (UV-POS)

Martin Busch; Susanne Wasmuth; Albrecht Lommatzsch; Solon Thanos; Daniel Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6045. doi:

ARVO Annual Meeting Abstract September 2016

Interplay of zinc, complement, and retinal pigment epithelial cells

Susanne Wasmuth; Martin Busch; Albrecht Lommatzsch; Daniel Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6558. doi:

ARVO Annual Meeting Abstract April 2014

ERK1/2 signaling pathway is activated by complement serum in UV-POS pretreated ARPE-19 cells

Martin Busch; Susanne Wasmuth; Albrecht Lommatzsch; Daniel Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):375. doi:

ARVO Annual Meeting Abstract April 2014

Activation of Primary Retinal Pigment Epithelial Cells by Complement Component C5a

Susanne Wasmuth; Martin Busch; Albrecht Lommatzsch; Daniel Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6334. doi:

ARVO Annual Meeting Abstract March 2012

Low Influence Of C5A On Retinal Pigment Epithelial Cells

Susanne Wasmuth; Katharina Lueck; Albrecht Lommatzsch; Daniel Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1235. doi:

Retinal Cell Biology March 2012

Complement and UV-Irradiated Photoreceptor Outer Segments Increase the Cytokine Secretion by Retinal Pigment Epithelial Cells

PDF

Katharina Lueck; Maren Hennig; Albrecht Lommatzsch; Daniel Pauleikhoff; Susanne Wasmuth
TAGS: bodily secretions, burkina faso, complement system proteins, cytokine, retinal pigment cell, ultraviolet rays, photoreceptors, cell culture techniques
Invest. Ophthalmol. Vis. Sci.. 2012; 53(3):1406-1413. doi: https://doi.org/10.1167/iovs.11-8889

ARVO Annual Meeting Abstract April 2011

The Ratio Of Pro- And Anti-angiogenic Cytokines Produced By Retinal Pigment Epithelial Cells Is Shifted To Support Angiogenesis By Complement

Susanne Wasmuth; Katharina Lueck; Kerstin Wendland; Albrecht Lommatzsch; Daniel Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2290. doi:

ARVO Annual Meeting Abstract April 2011

Complement stimulates Retinal Pigment Epithelial Cells to undergo Pro-inflammatory Changes as in Early Age-Related Macular Degeneration

Katharina Lueck; Susanne Wasmuth; Stephen E. Moss; John Greenwood; Albrecht Lommatzsch; Daniel Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2295. doi:

ARVO Annual Meeting Abstract April 2011

Results Of Prn-regimen In Anti-vegf Therapy For Amd In Clinical Practice

Britta E. Heimes; Albrecht Lommatzsch; Matthias Gutfleisch; Martha Dietzel; Meike Zeimer; Georg Spital; Daniel Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):113. doi:

ARVO Annual Meeting Abstract April 2010

Human Complement Sera Stimulates Basolateral Secretion of VEGF by Retinal Pigment Epithelial Cells

K. Lueck; S. Wasmuth; S. Moss; J. Greenwood; A. Lommatzsch; D. Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):6200. doi:

Immunology and Microbiology November 2009

Increased Vitronectin Production by Complement-Stimulated Human Retinal Pigment Epithelial Cells

PDF

Susanne Wasmuth; Katharina Lueck; Hanna Baehler; Albrecht Lommatzsch; Daniel Pauleikhoff
TAGS: complement system proteins, retinal pigment cell, vitronectin, proteins
Invest. Ophthalmol. Vis. Sci.. 2009; 50(11):5304-5309. doi: https://doi.org/10.1167/iovs.08-3326

ARVO Annual Meeting Abstract April 2009

Complement enhances the Vitronectin Production of Retinal Pigment Epithelial Cells

S. Wasmuth; K. Lueck; A. Lommatzsch; D. Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4177. doi:

ARVO Annual Meeting Abstract April 2009

Funktional and Morphological Results of Anti-VEGF Treatment of Vascularized Pigment Epithelial Detachment

A. P. Lommatzsch; B. Heimes; G. Spital; M. Gutfleisch; D. Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1889. doi:

ARVO Annual Meeting Abstract May 2008

Retinal Pigment Epithelial Cells are Impaired by Complement

S. Wasmuth; M. Hennig; K. Lück; M. Zeimer; G. Spital; A. Lommatzsch; D. Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5153. doi:

ARVO Annual Meeting Abstract May 2008

Prognostic Factors in Anti-VEGF Therapy in AMD

D. Pauleikhoff; B. Heimes; M. Dietzel; M. Zeimer; G. Spital; A. Lommatzsch; A. C. Bird

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2885. doi:

ARVO Annual Meeting Abstract May 2004

Matrix Metalloproteinases and Metalloproteinase Inhibitors in normal Bruch's Membrane and Basal Laminar Deposits

P. Hermans; A. Lommatzsch; K.–D. Mueller; N. Bornfeld; D. Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1788. doi:

ARVO Annual Meeting Abstract May 2004

Correlation of optical coherence tomography with fluorescein and indocyanine green angiography characteristics in patients with exudative age– related macular degeneration.

C. Gerth; G. Spital; I. Kroemer; A. Lommatzsch; D. Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3074. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Morphological changes of vascular structures in OCT angiography in MacTel type 2 and quantification of vascular density and flow areas in disease progression.

OCT angiography of type 1 and 2 CNV in exudative AMD under anti-VEGF therapy: Evaluation of a new quantitative method

Changes in OCT-Angiography of type 2 CNV in neovascular AMD during anti-VEGF treatment.

Proteomic changes in ARPE-19 cells stimulated with complement serum and UV-irradiated photoreceptor outer segments (UV-POS)

Interplay of zinc, complement, and retinal pigment epithelial cells

ERK1/2 signaling pathway is activated by complement serum in UV-POS pretreated ARPE-19 cells

Activation of Primary Retinal Pigment Epithelial Cells by Complement Component C5a

Low Influence Of C5A On Retinal Pigment Epithelial Cells

Complement and UV-Irradiated Photoreceptor Outer Segments Increase the Cytokine Secretion by Retinal Pigment Epithelial Cells

The Ratio Of Pro- And Anti-angiogenic Cytokines Produced By Retinal Pigment Epithelial Cells Is Shifted To Support Angiogenesis By Complement

Complement stimulates Retinal Pigment Epithelial Cells to undergo Pro-inflammatory Changes as in Early Age-Related Macular Degeneration

Results Of Prn-regimen In Anti-vegf Therapy For Amd In Clinical Practice

Human Complement Sera Stimulates Basolateral Secretion of VEGF by Retinal Pigment Epithelial Cells

Increased Vitronectin Production by Complement-Stimulated Human Retinal Pigment Epithelial Cells

Complement enhances the Vitronectin Production of Retinal Pigment Epithelial Cells

Funktional and Morphological Results of Anti-VEGF Treatment of Vascularized Pigment Epithelial Detachment

Retinal Pigment Epithelial Cells are Impaired by Complement

Prognostic Factors in Anti-VEGF Therapy in AMD

Matrix Metalloproteinases and Metalloproteinase Inhibitors in normal Bruch's Membrane and Basal Laminar Deposits

Correlation of optical coherence tomography with fluorescein and indocyanine green angiography characteristics in patients with exudative age– related macular degeneration.

To View More...

You must be signed into an individual account to use this feature.